Active ingredient of this medicine is a Rizatriptan Benzoate. It is a member of the triptan class agents with the anti-migraine property. This medication binds to and activates serotonin 1B receptors expressed in intracranial arteries, to 5-HT 1D receptors located on peripheral trigeminal sensory nerve terminals in the meninges, and central terminals in brain stem sensory nuclei. Receptor binding leads to constriction of cranial vessels and inhibition of nociceptive transmission. It is to provide relief of migraine headaches. It relieves migraine headaches by inhibition of pro-inflammatory neuropeptide release.
This medicine belongs to a group of medicines called selective serotonin 5-HT1B/1D receptor agonists. Maxalt-MLT is approved to treat the headache phase of the migraine attack in adults. It reduces swelling of blood vessels surrounding the brain that results in the headache pain of a migraine attack.
Rizatriptan composed medicine belongs to a group of medications known as 5-hydroxytryptamine agonists also called triptans. Maxalt -MLT is indicated to treat migraine headaches with or without aura. The pain of migraine headaches is thought to be caused by dilated blood vessels inside the head. It relieves migraine headaches by constricting these blood vessels.
- Sudden And Severe Stomach Pain
- Bloody Diarrhea
- Loss Of Coordination
This mentioned medicine is available for oral administration in the form of an orally disintegrating tablet in dosages as given below:
- 5 mg: It must be taken exactly as instructed by the doctor. Do not take extra amounts than prescribed
- 10 mg: This pill should be consumed as directed by the doctor
This drug is not recommended in people who have or have ever had heart problems including heart attack or pain on the chest or heart disease-related signs.